Practice question

Lipopolysaccharide defines outer leaflet of Gram-negative outer membrane and accounts for barrier properties and immune activation. Its lipid anchor, lipid A, determines endotoxin activity, while core polysaccharide and distal O-antigen provide antigenic variation. Lipid A consists of diglucosamine bisphosphate hexa-acylated with hydroxy fatty acids, a unique pathogen-associated molecular pattern detected by host innate receptor TLR4/MD-2 complex. Upon release during cell division, death, or antibiotic-induced lysis, lipid A stimulates macrophages to secrete potent mediators like tumor necrosis factor alpha, interleukin-1, and prostaglandins, provoking fever, leukocyte recruitment, and potentially septic shock cascade. Peptidoglycan itself is immunostimulatory via NOD receptors but not classic endotoxin, lipoteichoic acid characterizes Gram-positive envelope as TLR2 ligand, and phospholipids are inert structural lipids. Hence among Gram-negative envelope components, lipopolysaccharide, through its lipid A domain, is responsible for endotoxic properties, a concept central to understanding sepsis pathogenesis, Limulus amebocyte lysate testing, and development of lipid A antagonists like eritoran for therapeutic exploration. This mechanistic insight is relevant for competitive examinations such as CSIR-NET and GATE, where understanding molecular detail rather than memorization enables accurate interpretation of experimental data and pathway interconnections.